Analyst firms · Citigroup · BDX
Citigroup BDX price target and rating history
Becton Dickinson and Company (BDX) · Health Care
Citigroup rates Becton Dickinson and Company (BDX) Buy with a $233 price target, as of its latest action on Feb 3, 2026. It has published 5 rating actions on BDX since July 2022, including 2 upgrades and 2 downgrades. Across 6 firms with a BDX price target in the last 12 months, the median target is $191. Citigroup's $233 is 22% above that.
- Current rating
- Buy
- Price target
- $233
- Median target, all firms
- $191
- Actions on BDX
- 5
Citigroup price target on BDX
Every Citigroup rating on BDX
- Feb 3, 2026
- May 22, 2025
- Oct 1, 2024
- Dec 12, 2022
- Jul 11, 2022
How other firms rate BDX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $242 | Nov 6, 2026 |
| Wolfe Research | Outperform | Oct 20, 2026 | |
| UBS | Buy | $19 | Jul 28, 2026 |
| Evercore ISI | Outperform | $180 | May 4, 2026 |
| Goldman Sachs | Neutral | $167 | Apr 10, 2026 |
| Barclays | Overweight | $202 | Feb 10, 2026 |
| Citigroup | Buy | $233 | Feb 3, 2026 |
Questions about Citigroup and BDX
- What is Citigroup's price target for BDX?
- Citigroup's latest stated price target for Becton Dickinson and Company (BDX) is $233, from its action on Feb 3, 2026.
- What is Citigroup's rating on BDX?
- Citigroup rates BDX Buy, a bullish rating, as of Feb 3, 2026.
- When did Citigroup last change its view on BDX?
- On Feb 3, 2026, Citigroup resumes coverage at Buy, price target $233.
- How does Citigroup's BDX target compare with other analysts?
- Across 6 firms with a BDX price target in the last 12 months, the median target is $191. Citigroup's $233 is 22% above that.
More BDX rating histories
All Citigroup ratingsBDX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.